Search results for "REGISTRY"

showing 10 items of 273 documents

Inzidenz von Kinderkrebs nach Röntgendiagnostik im Patientenkollektiv der Jahre 1976 – 2003 einer Universitäts-Kinderklinik

2010

Purpose: Although the carcinogenic effect of ionizing radiation is well known, knowledge gaps persist on the health effects of low-dose radiation, especially in children. The cancer incidence rate in a cohort of 92,957 children diagnosed using X-rays in the years 1976-2003 in the radiology department of a large university clinic was studied. Materials and Methods: Individual radiation doses per examination were reconstructed using an algorithm taking into account the dose area product and other exposure parameters together with conversion factors computed specifically for the equipment and protocols used in the radiology department. Incident cancer cases in the period 1980-2006 were identif…

Pediatricsmedicine.medical_specialtyChildhood Cancer Registrybusiness.industryIncidence (epidemiology)Cancermedicine.diseaseSurgeryStandardized mortality ratioEpidemiologyCohortmedicineRadiology Nuclear Medicine and imagingPseudonymizedbusinessCohort studyRöFo - Fortschritte auf dem Gebiet der Röntgenstrahlen und der bildgebenden Verfahren
researchProduct

1035 The International Registry for Niemann-Pick Disease Type C (NP-C) in Clinical Practice

2012

Background and Aim An international disease registry was started in September 2009 to evaluate the long-term disease course of NP-C in clinical settings. Methods Descriptive data from enrolment are presented for all patients with available data who were included in the Registry as of 19 th August 2011. Results 121 patients have been enrolled. The median (range) age at enrolment was 16.9 (0.9−56.6) years, age at onset of neurological manifestations was 8.2 ( Conclusions Over two-thirds of this NP-C cohort had infantile or juvenile onset of neurological manifestations; neonatal jaundice was observed more frequently in these patients versus adolescent/adult-onset patients.

Pediatricsmedicine.medical_specialtyNiemann–Pick disease type Cbusiness.industryClinical settingsJaundicemedicine.diseaseDisease courseClinical PracticeJuvenile onsetDisease registryPediatrics Perinatology and Child HealthCohortmedicinemedicine.symptombusinessArchives of Disease in Childhood
researchProduct

Mental health and health-related quality of life in preschool-aged childhood cancer survivors. Results of the prospective cohort study ikidS-OEVA.

2021

Objectives Long-term survivors of childhood cancer are at increased risk for sequelae such as poor mental health (MH) or impaired health-related quality of life (HrQoL). We aimed to evaluate early adverse effects on MH and HrQoL in young childhood cancer survivors (YCCS) before school entry. Methods In a nationwide prospective cohort study, children with cancer other than brain tumors diagnosed at preschool age and completed cancer treatments were identified from the German Childhood Cancer Registry. The comparison group was children of the same age without a cancer diagnosis who participated in the prospective population-based health survey ikidS. MH problems and HrQoL were assessed by par…

Pediatricsmedicine.medical_specialtyPopulation03 medical and health sciences0302 clinical medicineQuality of lifeCancer SurvivorsNeoplasmsSurveys and QuestionnairesmedicineHumansEarly childhoodProspective StudiesProspective cohort studyeducationeducation.field_of_studyChildhood Cancer RegistrySchoolsbusiness.industryCancerHematologyStrengths and Difficulties Questionnairemedicine.diseaseMental healthMental HealthOncology030220 oncology & carcinogenesisChild PreschoolPediatrics Perinatology and Child HealthQuality of Lifebusiness030215 immunologyPediatric bloodcancerREFERENCES
researchProduct

Long-term disability trajectories in relapsing multiple sclerosis patients treated with early intensive or escalation treatment strategies

2021

Background and aims: No consensus exists on how aggressively to treat relapsing–remitting multiple sclerosis (RRMS) nor on the timing of the treatment. The objective of this study was to evaluate disability trajectories in RRMS patients treated with an early intensive treatment (EIT) or with a moderate-efficacy treatment followed by escalation to higher-efficacy disease modifying therapy (ESC). Methods: RRMS patients with ⩾5-year follow-up and ⩾3 visits after disease modifying therapy (DMT) start were selected from the Italian MS Registry. EIT group included patients who received as first DMT fingolimod, natalizumab, mitoxantrone, alemtuzumab, ocrelizumab, cladribine. ESC group patients rec…

Pediatricsmedicine.medical_specialtybig data; disability trajectories; disease registry; multiple sclerosis.multiple sclerosis03 medical and health sciences0302 clinical medicineDisease registrybig dataMedicine030212 general & internal medicineRC346-429Original Researchbig data; disability trajectories; disease registry; multiple sclerosisPharmacologybusiness.industryMultiple sclerosisLong term disabilitymedicine.diseaseNeurologydisease registryTreatment strategySettore MED/26 - Neurologiadisability trajectoriesNeurology. Diseases of the nervous systemNeurology (clinical)business030217 neurology & neurosurgeryTherapeutic Advances in Neurological Disorders
researchProduct

Epidemiology, aetiology and treatment of skin and soft tissue infections: final report of a prospective multicentre national registry

2022

Skin and soft tissue infections (SSTIs) represent a heterogenous group of pathological conditions involving the skin or the underlying subcutaneous tissues, fascia and muscle, characterised by a considerable variety of clinical presentations, severity and possible aetiological pathogens. Although previous analyses on restricted types of SSTIs and population have already been published, we conducted a large nationwide surveillance program on behalf of the Italian Society of Infectious and Tropical Diseases to assess the clinical and microbiological characteristics of the whole SSTI spectrum, from mild to severe life-threatening infections, in both inpatients and outpatients and their managem…

PharmacologyAdultRegistrieSoft Tissue InfectionsSoft Tissue Infections.SSTIComorbidityABSSSIregistryABSSSIs; SSTIs; registryABSSSIsAnti-Bacterial AgentsProspective StudieInfectious DiseasesOncologySSTIsItalyAnti-Bacterial AgentHumansPharmacology (medical)Prospective StudiesRegistriesHuman
researchProduct

Antiplatelets in acute coronary syndrome in Poland – from guidelines to clinical practice

2021

Acute coronary syndrome is a factor for poor prognosis and recurrent cardiovascular events. Adequate antiplatelet therapy is crucial in patients with the acute coronary syndrome for risk reduction. Such treatment is well described in four documents issued by the European Society of Cardiology, which precisely illustrate the use of antiplatelets in the settings of ST-elevated and non-ST elevated myocardial infarction. Despite its unquestioned role in the treatment of acute coronary syndrome, recent real-world-data from Polish registries reveal poor adherence to the guidelines-recommended antiplatelet treatment in Poland. Thus, we present here a comprehensive review of the use of antiplatelet…

Poor prognosismedicine.medical_specialtyAcute coronary syndromeReview Paperbusiness.industryRInvasive cardiologymedicine.diseaseantiplatelet treatmentnon-ST elevation myocardial infarctionPoor adherenceClinical PracticeST elevation myocardial infarctionmedicineMedicineIn patientNational registryMyocardial infarctionguidelinesCardiology and Cardiovascular MedicineIntensive care medicinebusinessPostępy w Kardiologii Interwencyjnej = Advances in Interventional Cardiology
researchProduct

Similar subjective response and adherence rates for long-acting risperidone and conventional depots

2008

Background and Aims:Amongst oral antipsychotics, tolerance and adherence are thought to be higher with atypicals versus conventional agents. Fewer data exist for parenteral antipsychotics regarding the atypical–conventional comparison.Aim:to compare adherence rates and subjective response between long-acting risperidone (LAR) and conventional depots.Methods:Cross-sectional, naturalistic, one-site study of all outpatients with severe mental disorders treated with injectable antipsychotics over a 12–month period at one Spanish mental health unit. Different sets of broadly– and narrowly–defined criteria for adherence were calculated from mental health nurse´s registry data. Patients´ subjectiv…

Psychiatry and Mental healthmedicine.medical_specialtySubjective responseRisperidoneSevere Mental Disordersbusiness.industryInternal medicineLong acting risperidonemedicineRegistry databusinessMental healthmedicine.drugEuropean Psychiatry
researchProduct

Lung cancer survival in Germany: A population-based analysis of 132,612 lung cancer patients.

2014

Lung cancer is the most common cancer-related death worldwide. In Germany it accounts for 25% of cancer deaths in men, and 14% in women. The aim of this study is to provide an overview of 5-year relative survival by sex, age, histology, and tumour stage in Germany representing a population of 26.7 million people.The study is based on a pooled German dataset including data from 12 population-based cancer registries covering around one third of the German population. A total of 132,612 patients diagnosed with lung cancer from 2002 to 2010 were included in the analysis. Survival estimates for the time period 2007-2010 were calculated using period analysis. Differences in survival between sexes…

Pulmonary and Respiratory MedicineGerontologyAdultMaleCancer ResearchLung NeoplasmsAdolescentPopulationAge adjustmentsymbols.namesakeYoung AdultSex FactorsGermanymedicineHumansPoisson regressionRegistrieseducationLung cancerAgedNeoplasm StagingAged 80 and overeducation.field_of_studyRelative survivalbusiness.industryAbsolute risk reductionAge FactorsCancerMiddle Agedmedicine.diseaseCancer registryOncologyPopulation SurveillancesymbolsFemalebusinessDemographyLung cancer (Amsterdam, Netherlands)
researchProduct

Riociguat treatment in patients with pulmonary arterial hypertension: Final safety data from the EXPERT registry

2021

OBJECTIVE: The soluble guanylate cyclase stimulator riociguat is approved for the treatment of adult patients with pulmonary arterial hypertension (PAH) and inoperable or persistent/recurrent chronic thromboembolic pulmonary hypertension following Phase 3 randomized trials. The EXPosurE Registry RiociguaT in patients with pulmonary hypertension (EXPERT) study was designed to monitor the long-term safety of riociguat in clinical practice. METHODS: EXPERT was an international, multicenter, prospective, uncontrolled, non-interventional cohort study of patients treated with riociguat. Patients were followed for at least 1 year and up to 4 years from enrollment or until 30 days after stopping ri…

Pulmonary and Respiratory Medicinemedicine.medical_specialtyRegistryMedDRAPeripheral edemaClinical practicePulmonary arterial hypertensionRiociguatlaw.inventionPulmonary hypertension03 medical and health sciences0302 clinical medicineRandomized controlled triallawInternal medicinemedicine030212 general & internal medicineAdverse effectHipertensió pulmonarRiociguatbusiness.industrymedicine.diseasePulmonary hypertensionClinical trial030228 respiratory systemPulmonary hemorrhagemedicine.symptomSafetybusinessmedicine.drug
researchProduct

Residential Exposure to PM2.5 Components and Risk of Childhood Non-Hodgkin Lymphoma in Denmark: A Nationwide Register-Based Case-Control Study

2020

In a recent study, we observed an increased risk of childhood non-Hodgkin lymphoma (NHL) associated with exposure to fine atmospheric particulate matter (PM2.5) and black carbon (BC). In this nationwide register-based case-control study, we focus on specific components of PM2.5 in relation to childhood NHL in Denmark (1981&ndash

Register basedMale010504 meteorology & atmospheric sciencesHealth Toxicology and MutagenesisChildhood Non-Hodgkin LymphomaDenmarkSecondary organic aerosolslcsh:Medicine01 natural sciencescomplex mixturesArticle03 medical and health scienceschemistry.chemical_compound0302 clinical medicineimmune system diseasesInterquartile rangehemic and lymphatic diseasesAir PollutionMedicineHumans030212 general & internal medicineChildsecondary inorganic aerosols0105 earth and related environmental sciencesAerosolsAir Pollutantsparticulate matter componentsSecondary organic aerosolsbusiness.industryLymphoma Non-Hodgkinlcsh:RPublic Health Environmental and Occupational HealthCase-control studyOdds ratiocarbonaceous particlesEnvironmental ExposureConfidence intervalCancer registryregister-based studychemistryCase-Control StudiesParticulate Matterbusinesschildhood Non-Hodgkin LymphomaDemographyEnvironmental MonitoringInternational Journal of Environmental Research and Public Health
researchProduct